GO
Loading...

What's behind these pharma M&A deals?

Tuesday, 22 Apr 2014 | 5:00 AM ET

The M&A activity in the pharmaceutical sector reveals that the industry is planning for the next 15-20 years, and is an opportunity for groups to diversify their tax bases, CNBC's Catherine Boyle explains.